Executive management

Fredrik Ullman
CEO since 2021 Born: 1980BSc in Mechanical Engineering from ETH Zürich and a MEng in Product Development from the KTH Royal Institute of Technology in Stockholm, a MScEng in Industrial engineering and Production, Supply Chain Management and Integrated Product Development and a PhD in Innovation and Technology Management from ETH Zürich.
Owner of Innoverse GmbH.
CEO of Indical Bioscience, various positions at Novozymes and Consultant at Bain & Company.
2,352,663 ordinary shares, 809,703 C shares.
Subscribed for a total of 250,836 warrants in the Company under LTI 2021.

Carl-Johan Zetterberg Boudrie
CFO since 2022 Born: 1978MSc in electrical engineering from the Royal Institute of Technology and MSc in economics from Stockholm University.
Owner of Calan Consulting AB.
CEO at Careium AB, CEO and CFO at DORO AB, CFO at Lekolar, Vice President Business Development at Beijer Electronics, and consultant at Capgemini Invent.
4,500 ordinary shares, 0 C shares.
Subscribed for a total of 41,071 warrants in the Company during LTI 2022.

Magnus Kjellberg
CEO of Nextmune since 2017 Born: 1973MSc in Business and Economics from the Stockholm School of Economics.
Chairman of the board of a number of subsidiaries within the Group. Board member of a number of subsidiaries within the Group and Nextmune Holding BV, Nextmune BV, Nextmune US LLC, Nextmune AS, Nextmune Scandinavia AB, Nextmune Spain S.L., Nextmune Italy S.r.l., Vetruus Limited and Bova UK Limited.
VP Corporate Strategy and M&A at Meda.
2 599 031 ordinary shares, 911 942 C shares.
Subscribed for a total of 125,418 warrants in the Company under LTI 2021.

Colleen Flesher
Co-CEO of Movora since 2022 Born: 1976MSc in Bioengineering from The University of Pennsylvania and MBA from The Pennsylvania State University.
President & General Manager Lima Corporate in the US, managerial positions in sales, marketing, product development and innovation at Synthes and Johnson & Johnson’s MedTech division.
0 ordinary shares, 0 C shares.
Subscribed for a total of 84,745 warrants in the Company under LTI 2022.

Guy C. Spörri
Co-CEO of Movora since 2020 Born: 1980MSc in Management, Technology and Economics from ETH Zürich.
Chairman of the board of KYON AG and Ossium AG. Board member of KYON Pharma (US).
CEO of Kyon, General Manager of Joint Replacement Division at Stryker and Sales Manager at Johnson & Johnson.
778,546 ordinary shares, 229,661 C shares.
Subscribed for a total of 83,612 warrants in the Company under LTI 2021 and 8,214 warrants under LTI 2022.

Alireza Tajbakhsh
CEO of VetFamily since 2022 Born: 1983MSc in Economics and Business Administration from the Stockholm School of Economics.
Chairman of the board and board member of a number of subsidiaries within the Group. Board member of Famano AB and Precis Holding AB (Precis Digital).
Group CEO of Omnicom Media Group Sweden, COO MTGx and Head of Digital MTG
Chairman of the Board OMD Sweden, Chairman of the Board PHD Sweden, Chairman of the Board Hearts & Science Sweden, Chairman of the Board Drum Sweden. Member of Board Splay Networks & Member of Board Godsmak.se.
292,064 ordinary shares and 125,170 C shares.
Subscribed for a total of 275,000 warrants in the Company under LTI 2022 and 10,000 warrants in the Company under LTI 2023.

Stefano Santarelli
CEO of Indical Bioscience since 2021 Born: 1981Bachelor of Economics (Honours) at LUISS Guido Carli University in Rome.
Ontario Teachers’ Pension Plan (OTPP), Bain & Company, Ernst & Young, TIM Telecom Italia, P&G.
0 ordinary shares, 0 C shares.
Subscribed for a total of 82,142 warrants in the Company under LTI 2022.

Martin Bengtson
Head of M&A since 2021 Born: 1981MSc in Finance from the Stockholm School of Economics.
Board member of HRR Holding AB and Danzinger Gatt Invest AB.
Head of M&A at Doktor.se, Group M&A Manager at AniCura and Investment Manager at Nordic Capital.
209,100 ordinary shares, 69,700 C shares.
0 warrants.

Maria Dahllöf Tullberg
Head of IR, Communications & Sustainability since 2021 Born: 1981MSc in Accounting and Financial Management from the Stockholm School of Economics.
Group Communications Director at AniCura, Head of Marketing & Communications at Moderna Försäkringar and Consultant at JKL Group.
7,300 ordinary shares, 0 C shares.
Subscribed for a total of 83,612 warrants in the Company under LTI 2021, 112,689 warrants under LTI 2022 and 80,000 warrants under LTI 2023.

Carl-Johan Ehn
General Counsel since 2022 Born: 1974Master of laws - LLM from Lund University
Bachelor of Business Administration – Finance from Lund University
Board member of Elding Oscarson Arkitekter AB
Board member of Tapster AB
Vice President and Chief Counsel International Operations at Zoetis
Assistant General Counsel at Pfizer
Attorney (Advokat) at Mannheimer Swartling Law Firm
17,000 ordinary shares.
Subscribed for a total of 112,689 warrants in the Company under LTI 2022 and 50,000 warrants in the Company under LTI 2023.